Provider of a health data analytics platform designed to collect and analyze continuous behaviour data and healthcare in
Provider of a health data analytics platform designed to collect and analyze continuous behaviour data and healthcare information to create better health outcomes.
Media and Information Services (B2B)📍 San Mateo, CAFounded 2012
Current Valuation
$1.0B
as of 2021-Q1
UNICORN
QL Price
$284.47M
-72% vs last round
QuantLogix's current estimate for Evidation Health, published 2026-09-07 — below the last disclosed round of $1.0B (2021-Q1).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.0B
2021-Q1
weight 0.02
Secondary market print
$259M
2026-06-27
weight 0.65
How this price has held up
No round has priced for Evidation Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-07 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Evidation Health, 2026-09-07 (aae77d583844ff4f).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Evidation Health going public?
No. Evidation Health is private and has not filed to go public. There is no S-1 on file.
What is Evidation Health's valuation in 2026?
Evidation Health is valued at $1.0B as of 2021-Q1, set by its Series E ($153M, Mar 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Evidation Health filed an S-1?
No public S-1 is on file for Evidation Health.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2012
HQ
San Mateo, CA
Employees
101
Total Raised
$259.16M
Last Round
Series E — $153M (Mar 2021)
IPO Status
private
Fundraising Status
Series E · $153M · 5y 6mo ago
privateTotal raised $259.16M
Secondary Market
Implied price / share
$4.8
Last round price / share
$18.51
vs last round
-74.1%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series E
$153M
Mar 2021
—
$1.0B
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
7
via careers page
Product-build share
14%
engineering, research, product, design
Trajectory
steady
go-to-market push — Only 14% of open roles build product — hiring is concentrated in sales/marketing/ops (2 of 7 open roles are marketing).
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Join ResearchOur CommunityOur PeopleEve: Evidation's brand mark which is a yellow glowing orbAnti-Bribery and Corruption PolicyFinancial Conflict of Interest Policy
Counted from Evidation Health's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q1. Refreshed quarterly.